Skip to main content
SpringerLink
Log in

Influence of recombinant human-soluble thrombomodulin on extracorporeal circuit clotting in septic patients undergoing blood purification: a propensity-matched cohort study

  • Original Article
  • Artificial Kidney / Dialysis
  • Published:
Journal of Artificial Organs Aims and scope Submit manuscript

Abstract

Blood purification has been widely performed for critically ill patients, even in cases without renal failure. Effective anticoagulation of the extracorporeal circuit is necessary to prevent circuit clotting. We hypothesized that administration of recombinant human-soluble thrombomodulin (rhsTM) to septic patients undergoing blood purification may prevent circuit clotting, because this agent regulates coagulation. We performed a retrospective, single-center, propensity-matched cohort study in the intensive care unit of Nishichita General Hospital. We included septic patients admitted to the intensive care unit from May 2015 to August 2020 who underwent blood purification. Patients who received rhsTM during intensive care unit admission to the end of the first blood purification (rhsTM group) were matched 1:1 with other patients (control group). The primary outcome was the occurrence of circuit clotting during the first blood purification. A total of 138 patients were included in the study [43 patients (31%) in the rhsTM group and 95 patients (69%) in the control group]. After propensity score matching, 42 pairs of patients were selected, and patients in the rhsTM group had a lower incidence of circuit clotting (21 vs. 55%, P = 0.003). One case of major bleeding occurred in the rhsTM group, but there was no difference in the incidence of major bleeding between groups (2 vs. 0%, P = 1.0). In conclusion, this propensity-matched cohort study indicated that the administration of rhsTM to septic patients undergoing blood purification may prevent extracorporeal circuit clotting.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Nishida O, Nakamura T, Kuriyama N, Hara Y, Yumoto M, Shimomura Y, et al. Sustained high-efficiency daily diafiltration using a mediator—adsorbing membrane (Shedd-fA) in the treatment of patients with severe sepsis. Contrib Nephrol. 2011;173:172–81.

    Article  CAS  Google Scholar 

  2. Nakamura M, Oda S, Sadahiro T, Hirayama Y, Watanabe E, Tateishi Y, et al. Treatment of severe sepsis and septic shock by CHDF using a PMMA membrane hemofilter as a cytokine modulator. Contrib Nephrol. 2010;166:73–82.

    Article  CAS  Google Scholar 

  3. Matsuda K, Moriguchi T, Oda S, Hirasawa H. Efficacy of continuous hemodiafiltration with a cytokine-adsorbing hemofilter in the treatment of acute respiratory distress syndrome. Contrib Nephrol. 2010;166:83–92.

    Article  CAS  Google Scholar 

  4. Nakamura M, Oda S, Sadahiro T, Hirayama Y, Tateishi Y, Abe R, et al. The role of hypercytokinemia in the pathophysiology of tumor lysis syndrome (TLS) and the treatment with continuous hemodiafiltration using a polymethylmethacrylate membrane hemofilter (PMMA-CHDF). Transfus Apher Sci. 2009;40:41–7.

    Article  Google Scholar 

  5. Srisawat N, Lawsin L, Uchino S, Bellomo R, Kellum JA. BEST Kidney Investigators. Cost of acute renal replacement therapy in the intensive care unit: Results from The Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) study. Crit Care. 2010;14:R46.

    Article  Google Scholar 

  6. Brandenburger T, Dimski T, Slowinski T, Kindgen-Milles D. Renal replacement therapy and anticoagulation. Best Pract Res Clin Anaesthesiol. 2017;31:387–401.

    Article  Google Scholar 

  7. Zarbock A, Küllmar M, Kindgen-Milles D, Wempe C, Gerss J, Brandenburger T, et al. Effect of regional citrate anticoagulation vs systemic heparin anticoagulation during continuous kidney replacement therapy on dialysis filter life span and mortality among critically Ill patients with acute kidney injury: a randomized clinical trial. JAMA. 2020;324:1629–39.

    Article  CAS  Google Scholar 

  8. Maruyama Y, Yoshida H, Uchino S, Yokoyama K, Yamamoto H, Takinami M, et al. Nafamostat mesilate as an anticoagulant during continuous veno-venous hemodialysis: a three-year retrospective cohort study. Int J Artif Organs. 2011;34:571–6.

    Article  CAS  Google Scholar 

  9. Mohri M. ART-123: recombinant human soluble thrombomodulin. Cardiovasc Drug Rev. 2000;18:312–25.

    Article  CAS  Google Scholar 

  10. Kienast J, Juers M, Wiedermann CJ, Hoffmann JN, Ostermann H, Strauss R, et al. Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation. J Thromb Haemost. 2006;4:90–7.

    Article  CAS  Google Scholar 

  11. du Cheyron D, Bouchet B, Bruel C, Daubin C, Ramakers M, Charbonneau P. Antithrombin supplementation for anticoagulation during continuous hemofiltration in critically ill patients with septic shock: a case-control study. Crit Care. 2006;10:R45.

    Article  Google Scholar 

  12. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801–10.

    Article  CAS  Google Scholar 

  13. Gando S, Wada H, Asakura H, Iba T, Eguchi Y, Okamoto K, et al. Evaluation of new Japanese diagnostic criteria for disseminated intravascular coagulation in critically ill patients. Clin Appl Thromb Hemost. 2005;11:71–6.

    Article  Google Scholar 

  14. Fu X, Liang X, Song L, Huang H, Wang J, Chen Y, et al. Building and validation of a prognostic model for predicting extracorporeal circuit clotting in patients with continuous renal replacement therapy. Int Urol Nephrol. 2014;46:801–7.

    Article  CAS  Google Scholar 

  15. Monchi M, Berghmans D, Ledoux D, Canivet JL, Dubois B, Damas P. Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: A prospective randomized study. Intensive Care Med. 2004;30:260–5.

    Article  Google Scholar 

  16. Oudemans-van Straaten HM. Hemostasis and thrombosis in continuous renal replacement treatment. Semin Thromb Hemost. 2015;41:91–8.

    Article  CAS  Google Scholar 

  17. Levi M, van der Poll T. Coagulation and sepsis. Thromb Res. 2017;149:38–44.

    Article  CAS  Google Scholar 

  18. Oudemans-van Straaten HM, van Schilfgaarde M, Molenaar PJ, Wester JP, Leyte A. Hemostasis during low molecular weight heparin anticoagulation for continuous venovenous hemofiltration: a randomized cross-over trial comparing two hemofiltration rates. Crit Care. 2009;13:R193.

    Article  Google Scholar 

  19. Shimomura Y, Suga M, Kuriyama N, Nakamura T, Sakai T, Kato Y, et al. Recombinant human thrombomodulin inhibits neutrophil extracellular trap formation in vitro. J Intensive Care. 2016;4:48.

    Article  Google Scholar 

  20. Valeriani E, Squizzato A, Gallo A, Porreca E, Vincent JL, Iba T, et al. Efficacy and safety of recombinant human soluble thrombomodulin in patients with sepsis-associated coagulopathy: a systematic review and meta-analysis. J Thromb Haemost. 2020;18:1618–25.

    Article  CAS  Google Scholar 

  21. Chua HR, Baldwin I, Bailey M, Subramaniam A, Bellomo R. Circuit lifespan during continuous renal replacement therapy for combined liver and kidney failure. J Crit Care. 2012;27:744.e7-15.

    Article  Google Scholar 

  22. Brain M, Winson E, Roodenburg O, McNeil J. Non anti-coagulant factors associated with filter life in continuous renal replacement therapy (CRRT): a systematic review and meta-analysis. BMC Nephrol. 2017;18:69.

    Article  Google Scholar 

Download references

Acknowledgements

We thank Yusuke Misu (Clinical Engineer) for their commitment to the study. We also thank Editage (www.editage.com) for English language editing.

Author information

Authors and Affiliations

  1. Department of Critical Care Medicine and Anesthesiology, Nishichita General Hospital, 3-1-1, Nakanoike, Tokai, Aichi, 477-8522, Japan

    Takuya Hinoue, Tomoaki Yatabe, Sohta Uchiyama & Takashi Ito

  2. Department of Anesthesiology and Critical Care Medicine, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan

    Takuya Hinoue & Osamu Nishida

  3. Gifu University Hospital Innovative and Clinical Research Promotion Center, Gifu University, 1-1, Yanagido, Gifu, Gifu, 501-1194, Japan

    Takuma Ishihara

Authors
  1. Takuya Hinoue
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tomoaki Yatabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sohta Uchiyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Takashi Ito
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Takuma Ishihara
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Osamu Nishida
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Tomoaki Yatabe or Osamu Nishida.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hinoue, T., Yatabe, T., Uchiyama, S. et al. Influence of recombinant human-soluble thrombomodulin on extracorporeal circuit clotting in septic patients undergoing blood purification: a propensity-matched cohort study. J Artif Organs 24, 485–491 (2021). https://doi.org/10.1007/s10047-021-01268-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10047-021-01268-2

Keywords

Search

Navigation